262
Views
45
CrossRef citations to date
0
Altmetric
Original Article

Treatment of Gastrointestinal Endocrine Tumours with Interferon-α and Octreotide

, , &
Pages 529-535 | Accepted 04 Jan 1991, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

IM Modlin, M Kidd, I Drozdov, Z-L Siddique & BI Gustafsson. (2008) Pharmacotherapy of neuroendocrine cancers. Expert Opinion on Pharmacotherapy 9:15, pages 2617-2626.
Read now
Isac I. Schnirer, James C. Yao & Jaffer A. Ajani. (2003) Carcinoid A Comprehensive Review. Acta Oncologica 42:7, pages 672-692.
Read now

Articles from other publishers (43)

Nagarjun Subash, Mishel Maria Papali, Khatri Prashant Bahadur, Chaithanya Avanthika, Sharan Jhaveri, Srijani Thannir, Meet Joshi & Sai Sudha Valisekka. (2022) Recent Advances in the Diagnosis and Management of Carcinoid Syndrome. Disease-a-Month 68:7, pages 101304.
Crossref
Larouche, Akirov, Alshehri & Ezzat. (2019) Management of Small Bowel Neuroendocrine Tumors. Cancers 11:9, pages 1395.
Crossref
Stephanie M Barrows, Beilei Cai, Catherine Copley-Merriman, Kelly R Wright, Colleen V Castro & Raoudha Soufi-Mahjoubi. (2018) Systematic literature review of the antitumor effect of octreotide in neuroendocrine tumors. World Journal of Meta-Analysis 6:2, pages 9-20.
Crossref
Krista Noonan, Jules Derks, Janessa Laskin & Anne-Marie C. Dingemans. 2018. IASLC Thoracic Oncology. IASLC Thoracic Oncology 555 568.e6 .
Marianne E Pavel. (2016) WOMEN IN CANCER PROFILE: Neuroendocrine tumors: moving from the land of small tumors to an expanding universe. Endocrine-Related Cancer 23:11, pages P23-P26.
Crossref
Peter J. Carolan & Daniel C. Chung. 2015. Yamada' s Textbook of Gastroenterology. Yamada' s Textbook of Gastroenterology 1782 1807 .
Anna Koumarianou & Nicola Fazio. 2015. Neuroendocrine Tumours. Neuroendocrine Tumours 275 298 .
Kjell Öberg. (2012) Biotherapies for GEP-NETs. Best Practice & Research Clinical Gastroenterology 26:6, pages 833-841.
Crossref
Alexandria T. Phan, Kjell Öberg, Junsung Choi, Lynn H. Harrison, Manal M. Hassan, Jonathan R. Strosberg, Eric P. Krenning, Walter Kocha, Eugene A. Woltering & William J. Maples. (2010) NANETS Consensus Guideline for the Diagnosis and Management of Neuroendocrine Tumors. Pancreas 39:6, pages 784-798.
Crossref
J. Philip Boudreaux, David S. Klimstra, Manal M. Hassan, Eugene A. Woltering, Robert T. Jensen, Stanley J. Goldsmith, Charles Nutting, David L. Bushnell, Martyn E. Caplin & James C. Yao. (2010) The NANETS Consensus Guideline for the Diagnosis and Management of Neuroendocrine Tumors. Pancreas 39:6, pages 753-766.
Crossref
R. SRIRAJASKANTHAN, C. TOUMPANAKIS, T. MEYER & M. E. CAPLIN. (2009) Review article: future therapies for management of metastatic gastroenteropancreatic neuroendocrine tumours. Alimentary Pharmacology & Therapeutics 29:11, pages 1143-1154.
Crossref
Florian Ehehalt, Hans D. Saeger, C. Max Schmidt & Robert Grützmann. (2009) Neuroendocrine Tumors of the Pancreas. The Oncologist 14:5, pages 456-467.
Crossref
Kimberly A. Varker, Jacqueline Campbell & Manisha H. Shah. (2007) Phase II study of thalidomide in patients with metastatic carcinoid and islet cell tumors. Cancer Chemotherapy and Pharmacology 61:4, pages 661-668.
Crossref
David A. Peterson, James P. Dolan & Jeffrey A. Norton. 2008. Surgery. Surgery 1249 1284 .
U. Plöckinger & B. Wiedenmann. (2007) Biotherapy. Best Practice & Research Clinical Endocrinology & Metabolism 21:1, pages 145-162.
Crossref
James C. Yao, Jun X. Zhang, Asif Rashid, Sai-Ching J. Yeung, Janio Szklaruk, Kenneth Hess, Keping Xie, Lee Ellis, James L. Abbruzzese & Jaffer A. Ajani. (2007) Clinical and In vitro Studies of Imatinib in Advanced Carcinoid Tumors . Clinical Cancer Research 13:1, pages 234-240.
Crossref
Chandrajit P. Raut, Matthew H. Kulke, Jonathan N. Glickman, Richard S. Swanson & Stanley W. Ashley. (2006) Carcinoid Tumors. Current Problems in Surgery 43:6, pages 391-450.
Crossref
Irvin M. Modlin, Igor Latich, Mark Kidd, Michelle Zikusoka & Geeta Eick. (2006) Therapeutic Options for Gastrointestinal Carcinoids. Clinical Gastroenterology and Hepatology 4:5, pages 526-547.
Crossref
Willscott E. Naugler & Gordon C. Hunt. 2006. Endoscopic Oncology. Endoscopic Oncology 161 172 .
W.W. de Herder. (2005) Tumours of the midgut (jejunum, ileum and ascending colon, including carcinoid syndrome). Best Practice & Research Clinical Gastroenterology 19:5, pages 705-715.
Crossref
U. Plöckinger & B. Wiedenmann. (2005) Management of metastatic endocrine tumours. Best Practice & Research Clinical Gastroenterology 19:4, pages 553-576.
Crossref
Irvin M. Modlin, Mark Kidd, Igor Latich, Michelle N. Zikusoka & Michael D. Shapiro. (2005) Current Status of Gastrointestinal Carcinoids. Gastroenterology 128:6, pages 1717-1751.
Crossref
Siegbert FaissUlrich-Frank PapeMichael BöhmigYvonne DörffelUlrich MansmannWerner GolderErnst Otto RieckenBertram Wiedenmann. (2003) Prospective, Randomized, Multicenter Trial on the Antiproliferative Effect of Lanreotide, Interferon Alfa, and Their Combination for Therapy of Metastatic Neuroendocrine Gastroenteropancreatic Tumors—The International Lanreotide and Interferon Alfa Study Group. Journal of Clinical Oncology 21:14, pages 2689-2696.
Crossref
James P. Dolan & Jeffrey A. Norton. 2003. Essential Practice of Surgery. Essential Practice of Surgery 401 415 .
Michelle L. Li & Jeffrey A. Norton. (2001) Gastrinoma. Current Treatment Options in Oncology 2:4, pages 337-346.
Crossref
Renier Brentjens & Leonard Saltz. (2001) ISLET CELL TUMORS OF THE PANCREAS. Surgical Clinics of North America 81:3, pages 527-542.
Crossref
James P. Dolan & Jeffrey A. Norton. 2001. Surgery. Surgery 919 953 .
Joseph R. Pisegna. (1999) The effect of Zollinger-Ellison syndrome and neuropeptide-secreting tumors on the stomach. Current Gastroenterology Reports 1:6, pages 511-517.
Crossref
J. Raedle & S. Zeuzem. 1999. Darmkrankheiten. Darmkrankheiten 371 382 .
William Caceres, Cesar Baldizon & Juan Sanchez. (1998) Carcinoid Tumor of the Thymus. American Journal of Clinical Oncology 21:1, pages 82-83.
Crossref
Muhammed Ashraf Memon & Heidi Nelson. (1997) Gastrointestinal carcinoid tumors. Diseases of the Colon & Rectum 40:9, pages 1101-1118.
Crossref
Michael C. Trendle, Charles G. Moertel & Larry K. Kvols. (2000) Incidence and morbidity of cholelithiasis in patients receiving chronic octreotide for metastatic carcinoid and malignant islet cell tumors. Cancer 79:4, pages 830-834.
Crossref
H.-J. Schmoll, H. Dralle, R. Arnold & E. Schmoll. 1997. Kompendium Internistische Onkologie. Kompendium Internistische Onkologie 836 861 .
Rudolf Arnold & Margareta Frank. (1996) Gastrointestinal endocrine tumours: Medical management. Baillière's Clinical Gastroenterology 10:4, pages 737-759.
Crossref
R Arnold, M E Trautmann, W Creutzfeldt, R Benning, M Benning, C Neuhaus, R Jurgensen, K Stein, H Schafer, C Bruns & H J Dennler. (1996) Somatostatin analogue octreotide and inhibition of tumour growth in metastatic endocrine gastroenteropancreatic tumours.. Gut 38:3, pages 430-438.
Crossref
S. Faiss, H. Scherübl, E. O. Riecken & B. Wiedenmann. 1996. New Perspectives in Molecular and Clinical Management of Gastrointestinal Tumors. New Perspectives in Molecular and Clinical Management of Gastrointestinal Tumors 193 207 .
A. G. HARRIS & J. S. REDFERN. (2007) Octreotide treatment of carcinoid syndrome: analysis of published dose‐titration data. Alimentary Pharmacology & Therapeutics 9:4, pages 387-394.
Crossref
Richard Cirelli & Stephen K. Tyring. (2012) Major Therapeutic Uses of Interferons. Clinical Immunotherapeutics 3:1, pages 27-87.
Crossref
J.H. Donohue. (1994) Malignant tumours of the small bowel. Surgical Oncology 3:2, pages 61-68.
Crossref
B. Greger & M. Rothmund. (1994) Invited commentary. World Journal of Surgery 18:4, pages 486-487.
Crossref
Joseph R. Pisegna, Grace G. Slimak, John L. Doppman, Doris B. Strader, David C. Metz, Richard V. Benya, Murray Orbuch, Vitaly A. Fishbeyn, Douglas L. Fraker, Jeffrey A. Norton, Paul N. Maton & Robert T. Jensen. (1993) An evaluation of human recombinant α interferon in patients with metastatic gastrinoma. Gastroenterology 105:4, pages 1179-1183.
Crossref
J. Gregory McKinnon. (2006) Palliative treatment of neuroendocrine tumors. Seminars in Surgical Oncology 9:5, pages 453-458.
Crossref
R. Arnold, R. Benning, C. Neuhaus, M. Rolwage & M.E. Trautmann. (1992) Gastroenteropancreatic endocrine tumors: Effect of Sandostatin® on tumor growth. Metabolism 41:9, pages 116-118.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.